Precision BioSciences (DTIL) Competitors $4.61 -0.03 (-0.65%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$4.63 +0.02 (+0.43%) As of 07/18/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DTIL vs. OGI, NLTX, PROK, ALMS, ELDN, CYBN, TIL, PBYI, VYGR, and TLSAShould you be buying Precision BioSciences stock or one of its competitors? The main competitors of Precision BioSciences include Organigram Global (OGI), Neoleukin Therapeutics (NLTX), ProKidney (PROK), Alumis (ALMS), Eledon Pharmaceuticals (ELDN), Cybin (CYBN), Instil Bio (TIL), Puma Biotechnology (PBYI), Voyager Therapeutics (VYGR), and Tiziana Life Sciences (TLSA). These companies are all part of the "pharmaceutical products" industry. Precision BioSciences vs. Its Competitors Organigram Global Neoleukin Therapeutics ProKidney Alumis Eledon Pharmaceuticals Cybin Instil Bio Puma Biotechnology Voyager Therapeutics Tiziana Life Sciences Organigram Global (NASDAQ:OGI) and Precision BioSciences (NASDAQ:DTIL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Which has more volatility and risk, OGI or DTIL? Organigram Global has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, Precision BioSciences has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Do institutionals and insiders believe in OGI or DTIL? 34.6% of Organigram Global shares are held by institutional investors. Comparatively, 38.0% of Precision BioSciences shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 4.5% of Precision BioSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher earnings and valuation, OGI or DTIL? Precision BioSciences has lower revenue, but higher earnings than Organigram Global. Precision BioSciences is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrganigram Global$117.47M1.65-$33.39M$0.1014.50Precision BioSciences$68.70M0.74$7.17M-$2.01-2.29 Do analysts prefer OGI or DTIL? Precision BioSciences has a consensus price target of $47.00, indicating a potential upside of 919.52%. Given Precision BioSciences' stronger consensus rating and higher probable upside, analysts plainly believe Precision BioSciences is more favorable than Organigram Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Precision BioSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to OGI or DTIL? In the previous week, Precision BioSciences had 3 more articles in the media than Organigram Global. MarketBeat recorded 4 mentions for Precision BioSciences and 1 mentions for Organigram Global. Precision BioSciences' average media sentiment score of 0.29 beat Organigram Global's score of 0.00 indicating that Precision BioSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Precision BioSciences 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is OGI or DTIL more profitable? Organigram Global has a net margin of 8.05% compared to Precision BioSciences' net margin of -42.99%. Organigram Global's return on equity of -5.93% beat Precision BioSciences' return on equity.Company Net Margins Return on Equity Return on Assets Organigram Global8.05% -5.93% -4.39% Precision BioSciences -42.99%-69.26%-29.30% SummaryPrecision BioSciences beats Organigram Global on 9 of the 16 factors compared between the two stocks. Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DTIL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DTIL vs. The Competition Export to ExcelMetricPrecision BioSciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.45M$2.95B$5.55B$9.40BDividend YieldN/A2.47%3.75%4.03%P/E Ratio-2.2919.7528.0119.82Price / Sales0.74300.24432.8198.20Price / CashN/A42.5936.1658.27Price / Book0.677.678.125.65Net Income$7.17M-$55.28M$3.25B$257.91M7 Day Performance3.60%4.85%1.68%3.38%1 Month Performance-1.91%11.70%7.30%11.11%1 Year Performance-53.34%3.69%32.89%18.99% Precision BioSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DTILPrecision BioSciences4.2737 of 5 stars$4.61-0.6%$47.00+919.5%-53.6%$51.45M$68.70M-2.29200News CoverageOGIOrganigram Global0.8609 of 5 stars$1.39-2.8%N/A-10.5%$191.53M$117.47M13.90860NLTXNeoleukin TherapeuticsN/A$20.09+1.7%N/A-49.0%$188.81MN/A-6.4690PROKProKidney3.5415 of 5 stars$0.61-4.8%$3.50+477.1%+43.8%$186.51M$306K-1.013Analyst ForecastALMSAlumis2.6423 of 5 stars$3.31-2.6%$22.86+590.5%-73.4%$184.98MN/A0.00N/ANews CoverageELDNEledon Pharmaceuticals1.8391 of 5 stars$3.11+1.0%$9.00+189.4%+39.6%$184.44MN/A-1.4810CYBNCybin3.0583 of 5 stars$7.87-0.9%$86.00+992.8%N/A$181.20MN/A-1.8050News CoverageTILInstil Bio3.1477 of 5 stars$23.64-14.0%$119.00+403.4%+106.8%$180.37MN/A-1.97410Positive NewsHigh Trading VolumePBYIPuma Biotechnology4.1317 of 5 stars$3.54-1.1%$7.00+97.7%-8.1%$177.68M$230.50M4.60200Positive NewsVYGRVoyager Therapeutics4.0133 of 5 stars$3.04-5.0%$13.39+340.5%-61.6%$177.08M$80M-2.08100News CoverageTLSATiziana Life Sciences1.232 of 5 stars$1.53+1.3%N/A+82.4%$176.44MN/A0.008 Related Companies and Tools Related Companies Organigram Global Alternatives Neoleukin Therapeutics Alternatives ProKidney Alternatives Alumis Alternatives Eledon Pharmaceuticals Alternatives Cybin Alternatives Instil Bio Alternatives Puma Biotechnology Alternatives Voyager Therapeutics Alternatives Tiziana Life Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DTIL) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DTIL Stock Alerts